How Samsung is innovating the way we monitor embryos
In an attempt to fully monitor the skeletal muscle systems of embryos during pregnancy, South Korea-based Samsung Electronics has developed an ultrasound diagnosis technology in collaboration with its medical equipment affiliate Samsung Medison.
The diagnosis innovation called Crystal View technology allows doctors to monitor musculoskeletal systems of embryos through the company’s own diagnostic ultrasound technique. It is expected to improve the accuracy of treatments through allowing medical personnel to monitor en embryo’s health conditions in more detail.
RELATED TOPIC: How Faros will bring artificial technology and software to healthcare
According to Samsung, the technology will receive government approval in within the next month, while market analysts anticipate the technology will surpass existing systems that show the 3D reconstruction of embryonic structures.
One of the leading electronics manufacturers in the world, Samsung has had a long desire to break into the healthcare sector, particularly cultivating diagnostic medical imaging technology.
RELATED TOPIC: Why the Samsung Medical Center is not to blame for the spread of MERS disease
“Through our innovative designs and advanced technologies, we remain committed to delivering new solutions that unlock workflow efficiencies for medical professionals as well as improve patients’ lives,” said Samsung Electronics president and head of the health and medical equipment business Soo-In Cho.
“By leveraging the combination of Samsung imaging technology and user-inspired design, we will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”
Let's connect! 
Click here to read the latest edition of Healthcare Global magazine!